In a subgroup including patients continuing statin therapy during follow-up ( n = 147 ) , the reduction in plasma total cholesterol concentrations was more pronounced in the intervention group than in the control group , 66.13 mg/dL versus 55.68 mg/dL ( P = .027 ) .